Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
International Journal of Clinical Practice
|
May 1, 2004
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet
C Lines, W H Visser
Current Medical Research and Opinion
|
December 5, 2002
Rizatriptan: pharmacological differences from sumatriptan and clinical results
C R Lines, K A McCarroll, W H Visser
Cephalalgia : an International Journal of Headache
|
December 1, 1996
Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients
W H Visser, N M Jaspers, R H de Vriend, et al.
Headache
|
September 1, 1996
Sumatriptan-nonresponders: a survey in 366 migraine patients
W H Visser, R H de Vriend, N H Jaspers, et al.
Neurology
|
July 1, 1996
Sumatriptan in clinical practice: a 2-year review of 453 migraine patients
W H Visser, R H de Vriend, M W Jaspers, et al.
Cephalalgia : an International Journal of Headache
|
June 1, 1996
Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients
W H Visser, N M Jaspers, R H de Vriend, et al.
Cephalalgia : an International Journal of Headache
|
October 1, 1992
Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group
W H Visser, M D Ferrari, E M Bayliss, et al.
Neurology
|
February 1, 1996
311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study
W H Visser, K B Klein, R C Cox, et al.
Pharmacoeconomics
|
April 4, 2001
The multinational impact of migraine symptoms on healthcare utilisation and work loss
W C Gerth, G W Carides, E J Dasbach, et al.
Medgenmed : Medscape General Medicine
|
September 11, 2001
Long-term efficacy and tolerability of rizatriptan wafers in migraine
R Cady, G Crawford, S Ahrens, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
International Journal of Clinical Practice
|
May 1, 2004
Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet
C Lines, W H Visser
Current Medical Research and Opinion
|
December 5, 2002
Rizatriptan: pharmacological differences from sumatriptan and clinical results
C R Lines, K A McCarroll, W H Visser
Cephalalgia : an International Journal of Headache
|
December 1, 1996
Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients
W H Visser, N M Jaspers, R H de Vriend, et al.
Headache
|
September 1, 1996
Sumatriptan-nonresponders: a survey in 366 migraine patients
W H Visser, R H de Vriend, N H Jaspers, et al.
Neurology
|
July 1, 1996
Sumatriptan in clinical practice: a 2-year review of 453 migraine patients
W H Visser, R H de Vriend, M W Jaspers, et al.
Cephalalgia : an International Journal of Headache
|
June 1, 1996
Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients
W H Visser, N M Jaspers, R H de Vriend, et al.
Cephalalgia : an International Journal of Headache
|
October 1, 1992
Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group
W H Visser, M D Ferrari, E M Bayliss, et al.
Neurology
|
February 1, 1996
311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study
W H Visser, K B Klein, R C Cox, et al.
Pharmacoeconomics
|
April 4, 2001
The multinational impact of migraine symptoms on healthcare utilisation and work loss
W C Gerth, G W Carides, E J Dasbach, et al.
Medgenmed : Medscape General Medicine
|
September 11, 2001
Long-term efficacy and tolerability of rizatriptan wafers in migraine
R Cady, G Crawford, S Ahrens, et al.
Page
of 2